CHRISTINE MOORE: Open Payments
NPI 1235131574 · RAYMORE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,513 in 154 payments from 29 companies in 2025. Trend: 2023 $21,111 · 2024 $16,094 · 2025 $10,513
Speaker / faculty: $7,485Food & beverage: $2,536Travel & lodging: $316Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $4,171 |
| Otsuka America Pharmaceutical, Inc. | 16 | $4,142 |
| Amgen Inc. | 17 | $378 |
| PFIZER INC. | 20 | $314 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $207 |
| AstraZeneca Pharmaceuticals LP | 10 | $176 |
| Lilly USA, LLC | 8 | $135 |
| Axsome Therapeutics, Inc. | 6 | $129 |
| Medtronic, Inc. | 1 | $108 |
| Lundbeck LLC | 5 | $103 |
Products named: REXULTI, VRAYLAR, NURTEC ODT, CAPLYTA, PROLIA, OTEZLA, AIRSUPRA, MOUNJARO.
Industry payments across MO — which companies pay providers there.
